Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05709210

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.

Conditions: Alzheimer Disease, Memory Disorders

Sex: All
Ages: 60 Years – N/A
Phase: NA
Enrollment: 90
Sponsor: Poitiers University Hospital

Location: France

Summary

This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.

Eligibility Criteria

Inclusion Criteria:Patient consulting in routine care in one of the CMRRNo sensory impairment that may compromise smartphone useExclusion Criteria:Inability to perform MMSE or MMSE < 20 ;Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)Severe anxiety or depressive disorder HADS score ≥ 17Terminal phase of a severe diseaseEvidence of a lesion on MRI that may be involved in cognitive impairment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05709210). StuddyBuddy aggregates publicly available trial information.